Eva Villar-Alvarez

Eva Villar-Alvarez

Auto-generated profile, based on publicly available information

Eva Villar-Alvarez

Grupo de Física de Coloides y Polímeros, Departamento de Física de la Materia Condensada; Universidad de Santiago de Compostela, 15782 Santiago de Compostela, Spain

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2014 in ACS Nano
Verified
Journal Article
Closed access
ATAntonio Topete
Antonio Topete
MAManuel Alatorre-Meda
Manuel Alatorre-Meda
PVPablo Iglesias Vazquez
Pablo Iglesias Vazquez
EVEva M. Villar-Alvarez
Eva M. Villar-Alvarez
SBSilvia Barbosa
Silvia Barbosa
VMVíctor Mosquera
Víctor Mosquera

1 January 2016 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
RCRosa Crespo
Rosa Crespo
EVEva Villar-Alvarez
Eva Villar-Alvarez
pablo Taboadapablo Taboada
pablo Taboada
FRFernando Rocha
Fernando Rocha
ADAna M. Damas
Ana M. Damas
PMP. M. Martins
P. M. Martins
Some of the most prevalent neurodegenerative diseases are characterized by the accumulation of amyloid fibrils in organs and tissues. While the pathogenic role of these fibrils is not totally established, increasing evidences suggest off-pathway aggregation (OPA) as a source of toxic/detoxicating deposits that still remains to be targeted. The present work is a step ahead towards the development of off-pathway modulators using the same amyloid-specific dyes as those conventionally employed to screen amyloid inhibitors. We identified a series of kinetic signatures revealing the quantitative importance of OPA relatively to amyloid fibrillization; these include non-linear semi-log plots of amyloid progress curves, highly variable endpoint signals and half-life coordinates weakly influenced by concentration. Molecules that attenuate/intensify the magnitude of these signals are considered promising off-pathway inhibitors/promoters. An illustrative example shows that amyloid deposits of lysozyme are only the tip of an iceberg hiding a crowd of insoluble aggregates. Thoroughly validated using advanced microscopy techniques and complementary measurements of Dynamic Light Scattering (DLS), Circular Dichroism (CD) and soluble protein depletion, the new analytical tools are compatible with the high-throughput methods currently employed in drug discovery.

25 April 2014 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
PDF file
ATAntonio Topete
Antonio Topete
MAManuel Alatorre-Meda
Manuel Alatorre-Meda
EVEva M. Villar‐Alvarez
Eva M. Villar‐Alvarez
SRSusana Romero
Susana Romero
SBSilvia Barbosa
Silvia Barbosa
VMVíctor Mosquera
Víctor Mosquera

16 October 2014 in The Journal of Physical Chemistry C
Verified
Journal Article
Closed access
SBSilvia Barbosa
Silvia Barbosa
ATAntonio Topete
Antonio Topete
MAManuel Alatorre-Meda
Manuel Alatorre-Meda
EVEva M. Villar-Alvarez
Eva M. Villar-Alvarez
APAlberto Pardo
Alberto Pardo
VMVíctor Mosquera
Víctor Mosquera

24 June 2014 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
ATAntonio Topete
Antonio Topete
MAManuel Alatorre-Meda
Manuel Alatorre-Meda
EVEva M. Villar-Álvarez
Eva M. Villar-Álvarez
ACAdriana Cambón
Adriana Cambón
SBSilvia Barbosa
Silvia Barbosa
VMVíctor Mosquera
Víctor Mosquera

20 January 2016 in Journal of Polymer Science Part A: Polymer Chemistry
Verified
Journal Article
Closed access
PDF file
GAGarbiñe Aguirre
Garbiñe Aguirre
EVEva Villar‐Alvarez
Eva Villar‐Alvarez
AGAdrián González
Adrián González
JRJose Ramos
Jose Ramos
pablo Taboadapablo Taboada
pablo Taboada
JFJacqueline Forcada
Jacqueline Forcada